Literature DB >> 8972750

Acute toxicity of curative radiotherapy in elderly patients.

P Huguenin1, C Glanzmann, U M Lütolf.   

Abstract

AIM: One reason for obvious differences in cancer treatment of elderly patients, compared to younger patients, may be the fear of reduced tolerance at a higher age. The purpose of the study was to document acute tolerance of radiotherapy with curative intent in patients > 74 years old. Special emphasis was given to 72 patients treated to large volumes and/or high doses for gynecological carcinomas, prostate cancer of subsites of the head and neck requiring bilateral treatment of the neck including major parts of the pharynx and larynx. PATIENTS AND
METHOD: From January 1991 to May 1995, 210 consecutive patients entered a prospective study to assess acute toxicity of radiotherapy given with curative intent. Median age was 79.3 (74.4 to 93.7) years. Fifty-three percent received postoperative radiotherapy, 47% radiotherapy alone. Radiation technique, fractionation and doses were the same as applied in younger patients. Tolerance was scored using a 5-point scale; in addition, pre- and post-treatment Karnofsky performance status and body weight were assessed.
RESULTS: Acute toxicity leads to a dose reduction in 3 patients. The death of 1 patient with Hodgkin's disease was attributable to large field radiotherapy, and 1 case of grade 4 cystitis was noted in a patient with prostate cancer. Radiotherapy for breast cancer with or without lymph nodes imposed no problem. With appropriate supportive measures, even hyperfractionated or accelerated radiotherapy regimens for carcinomas of the head and neck were feasible in elderly patients. Radiotherapy to the pelvic region lead to severe diarrhea requiring medication in 20% of the patients. For all areas treated, higher age within the range of > 74 to < 94 years did not increase the severity of the acute radiation reactions.
CONCLUSIONS: Using the same treatment schedules and techniques of radiotherapy as for younger patients, curative radiotherapy is well tolerated in patients aged > 74 years treated even when major parts of the pharynx and larynx or large volumes of the pelvis are included. Small bowel reaction (diarrhea) and pharyngeal mucositis deserve special attention and supportive care in elderly patients prone to a rapidly symptomatic dehydration.

Entities:  

Mesh:

Year:  1996        PMID: 8972750

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  7 in total

1.  [No age limit for curative radiation of head and neck as well as pelvic tumors].

Authors:  P Huguenin
Journal:  Strahlenther Onkol       Date:  1998-02       Impact factor: 3.621

Review 2.  [Radiotherapy of the elderly patient. Radiotherapy tolerance and results in older patients].

Authors:  H Geinitz; F B Zimmermann; M Molls
Journal:  Strahlenther Onkol       Date:  1999-03       Impact factor: 3.621

Review 3.  Early breast cancer in the older woman.

Authors:  Sonal Gandhi; Sunil Verma
Journal:  Oncologist       Date:  2011-03-17

Review 4.  Quality-of-life considerations in the treatment of early-stage breast cancer in the elderly.

Authors:  Toralf Reimer; Bernd Gerber
Journal:  Drugs Aging       Date:  2010-10-01       Impact factor: 3.923

Review 5.  Adjuvant therapy for women over age 65 with breast cancer.

Authors:  Marie-Luise Sautter-Bihl; Rainer Souchon; Bernd Gerber
Journal:  Dtsch Arztebl Int       Date:  2011-05-27       Impact factor: 5.594

Review 6.  Combined modality therapy in the elderly population.

Authors:  Lilie L Lin; Stephen M Hahn
Journal:  Curr Treat Options Oncol       Date:  2009-06-09

7.  Postoperative Radiotherapy for Endometrial Cancer in Elderly (≥80 Years) Patients: Oncologic Outcomes, Toxicity, and Validation of Prognostic Scores.

Authors:  Eva Meixner; Kristin Lang; Laila König; Elisabetta Sandrini; Jonathan W Lischalk; Jürgen Debus; Juliane Hörner-Rieber
Journal:  Cancers (Basel)       Date:  2021-12-14       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.